Ayush Exports Gets a Boost as Ayushexcil Joins Official Certifying Agencies

A step in the direction of streamlining and simplification of the export procedure for India's traditional medicinal industry, the Ministry of Commerce and Industry

India to Boost its PLI Initiative for Drug Manufacturing

India is about to give a significant boost to its production-linked incentive (PLI) scheme for pharmaceuticals as it seeks to establish a stronger domestic production of key starting materials (KSMs)...

Zydus to acquire US biotech firm Agenus in Emeryville and Berkeley

Zydus Lifesciences is entering the global biologics contract development and manufacturing (CDMO) arena with its acquisition of two biologics facilities from Agenus at Emeryville and Berkeley in California...

TDB Drives Local Innovation in Complex Pharma Excipients

Indian Technology Development Board (TDB), which operates under Department of Science and Technology (DST), has provided finance support to excipient producer of pharmaceuticals

Indian Pharma Industry Set for Growth Following Fiji's Pharmacopoeia Nod

The Indian Pharmacopoeia (IP) was refurbished to consider as a gold standard and taken to the extent of benchmarking by the Indian Pharmacopoeia Commission

Biocon Received Approval in India for its Liraglutide Drug Substance

Biocon Limited, a global biopharmaceutical company focused on innovation, announced today that its Liraglutide drug substance has been approved in India. In addition, Biocon Pharma Limited, a wholly...

BDCDA Urges Government Task Force to Tackle Counterfeit Drug Menace

Bangalore District Chemists & Druggists Association (BDCDA) has urged the Karnataka state government to establish a high-level task force for enforcement

Glenmark Announced Promising Results For Blood Cancer Drug

Ichnos Glenmark Innovation (IGI), a clinical-stage biotech collaboration between New York-based Ichnos Sciences and India’s Glenmark Pharmaceuticals, has presented encouraging Phase 1 data for its...

AyushSuraksha Portal launched address misleading advertisements and ADR

Following direction from the Supreme Court of India in July 2024, the Ministry of Ayush has introduced AyushSuraksha Portal to handle fake advertisements and report adverse drug reactions (ADRs)...

Sun Pharma to Invest $100M in Specialty Drug Launches This Fiscal

According to Chairman and Managing Director Dilip Shanghvi, Sun Pharmaceutical Industries has secured a USD 100 million investment to commercialize innovative pharmaceuticals in the current fiscal year

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.